PolyPeptide Group (Hangzhou): difference between revisions
Diff·revision 12 → 13·13:57, 7 Nov 2025
Difference between revision 12 and revision 13 of PolyPeptide Group (Hangzhou). 12 lines changed; the page grew by 1,150 bytes.
| Revision 12 — 16:42, 30 Oct 2025 ReportReaderRilla (talk) add category for suppliers in China 8,468 bytes +381 | Revision 13 — 13:57, 7 Nov 2025 AnalyticalAnnie (talk) expand §Distribution and dispatch 9,618 bytes +1,150 | ||
|---|---|---|---|
| 54 | Listings and their descriptions are taken from the organisation's own catalogue and are recorded as self-published.{{r|selfpub}} The count above the table is the organisation's own figure; this wiki has not enumerated the catalogue and does not adopt the number as a finding. | 54 | Listings and their descriptions are taken from the organisation's own catalogue and are recorded as self-published.{{r|selfpub}} The count above the table is the organisation's own figure; this wiki has not enumerated the catalogue and does not adopt the number as a finding. |
| 55 | 55 | ||
| + | 56 | == Independent testing record == | |
| + | 57 | Reports on PPG material submitted to PeptidePedia between 2024 and 2026 cover the incretin analogues most heavily, with a smaller set on repair peptides and a handful on bulk raw material. Reported [[Area percent purity|area percent]] figures have been high across the set, and where a report and the accompanying certificate can be compared the two have agreed within a few tenths of a percentage point.{{r|reports}} | |
| + | 58 | ||
| + | 59 | Agreement of that kind is a weaker finding than it appears. It establishes that two measurements of one sample agreed; it establishes nothing about the lot the sample was drawn from, because none of these reports arose from a [[Blind sampling|blind sample]] of production.{{r|reports}} The reproduced chromatogram narrows one part of that gap and not the others: it allows a reader to check that the declared figure was drawn honestly from the injection shown, which is a real check and a small one against the question of what is in an arbitrary vial. | |
| + | 60 | ||
| 56 | == References == | 61 | == References == |
| 57 | {{reflist}} | 62 | {{reflist}} |
| ⋮ | ⋮ | ||
| 61 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 66 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| 62 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 67 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| + | 68 | ||
| + | 69 | == See also == | |
| + | 70 | * [[Certificate of analysis]] | |
| + | 71 | * [[Third-party testing]] | |
| + | 72 | * [[Area percent purity]] | |
| + | 73 | * [[Peptide content]] | |
| + | 74 | * [[Research use only]] | |
| 63 | 75 | ||
| 64 | {{DEFAULTSORT:PolyPeptide Group (Hangzhou)}} | 76 | {{DEFAULTSORT:PolyPeptide Group (Hangzhou)}} |